"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Pharmatest Services Ltd attends ASBMR Annual Meeting in Atlanta

Pharmatest Services Ltd attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that will be held in Atlanta, GA, USA on September 16 – 19, 2016. Pharmatest has four scientific presentations in the meeting and we welcome everyone to visit our booth #109.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. ASBMR Annual Meeting is the leading scientific event in the field of bone research globally.

This year Pharmatest attends ASBMR with the following four scientific presentations:

- Poster FR0052 and SA0052 on Friday, September 16 (plenary poster) and Saturday, September 17:  Effects of cabozantinib alone and in combination with bortezomib in the 5TGM1 murine multiple myeloma model (collaboration with Exelixis Inc.)

- Poster SA0318on Saturday, September 17: Changes of Articular Cartilage and Subchondral Bone in Rat Osteoarthritis Model Induced by Surgical MMT and MCLT Operation (funded by Eurostars program of EU)

- Poster SU0317 on Sunday, September 18: The Effects of Intra-Articular Treatment with Recombinant Human Bone Morphogenetic Protein 7 (rhBMP-7) on the Development of Post-Traumatic Osteoarthritis in Surgically Induced Rat Models (funded by Eurostars program of EU)

Pharmatest is welcoming everyone to visit our posters and booth #109 in the event. If you would like to schedule a meeting with our representatives during the ASBMR meeting click here.